Andrew Bayliffe

Company: Marengo Therapeutics Inc.

Job title: Chief Scientific Officer

Seminars:

Selectively Activating Subsets of T Cells Present in Tumor-Infiltrating Lymphocytes of Solid Tumors to Promote More Potent Anti-Tumor Activity 4:00 pm

Uncovering associations between Vβ T cell subsets and diseases, including specific cancers, autoimmune and infectious diseases Outlining the strategy of stimulating only a defined subset of αβ T cells Exploring Marengo’s pipeline of novel TCEs for both hot and cold tumorsRead more

day: Day Two